First CRISPR Cas9 drug dispute breaks out with suits in the Netherlands and the UK
Vertex has filed a Dutch revocation action against ToolGen, which has responded with an English infringement action Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to …